Endurant Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-80,455
| Closed | -$492K | – | 44 |
|
|
2023
Q1 | $492K | Buy |
80,455
+9,800
| +14% | +$59.9K | 0.25% | 42 |
|
|
2022
Q4 | $451K | Buy |
+70,655
| New | +$451K | 0.18% | 48 |
|
|
2022
Q2 | – | Sell |
-60,720
| Closed | -$1.01M | – | 63 |
|
|
2022
Q1 | $1.01M | Buy |
60,720
+6,739
| +12% | +$112K | 0.27% | 52 |
|
|
2021
Q4 | $1.03M | Sell |
53,981
-77,117
| -59% | -$1.47M | 0.25% | 56 |
|
|
2021
Q3 | $3.23M | Sell |
131,098
-29,264
| -18% | -$722K | 0.74% | 32 |
|
|
2021
Q2 | $4.17M | Sell |
160,362
-150,287
| -48% | -$3.91M | 1.15% | 35 |
|
|
2021
Q1 | $9.84M | Buy |
310,649
+256,428
| +473% | +$8.12M | 2.56% | 13 |
|
|
2020
Q4 | $2.52M | Buy |
+54,221
| New | +$2.52M | 0.91% | 36 |
|
|
2020
Q2 | – | Sell |
-20,207
| Closed | -$605K | – | 64 |
|
|
2020
Q1 | $605K | Sell |
20,207
-148,339
| -88% | -$4.44M | 0.27% | 42 |
|
|
2019
Q4 | $4.67M | Buy |
168,546
+82,477
| +96% | +$2.28M | 1.47% | 21 |
|
|
2019
Q3 | $1.57M | Sell |
86,069
-87,169
| -50% | -$1.59M | 0.56% | 31 |
|
|
2019
Q2 | $4.25M | Buy |
+173,238
| New | +$4.25M | 1.67% | 26 |
|
|
2019
Q1 | – | Sell |
-318,185
| Closed | -$2.82M | – | 73 |
|
|
2018
Q4 | $2.82M | Buy |
318,185
+76,016
| +31% | +$673K | 1.49% | 22 |
|
|
2018
Q3 | $2.72M | Buy |
+242,169
| New | +$2.72M | 1.21% | 27 |
|